Cellular Biology |
From the Department of Medicine (K.I., X.Y., M.T., B.H.L.), Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Mass; and Division of Cardiology (Z.S., W.H.B.), University of Utah Health Sciences Center (Salt Lake City).
Correspondence to Beverly H. Lorell, MD, Cardiovascular Division, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215. E-mail blorell{at}caregroup.harvard.edu
| Abstract |
|---|
|
|
|---|
Key Words: myocytes contractility sarcoplasmic reticulum Ca2+-ATPase heart failure hypertrophy
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Simultaneous Measurement of
[Ca2+]i and Cell Motion
Myocyte contraction and
[Ca2+]i measured with
fluo-3 were monitored simultaneously in LV myocytes. The
calibration procedure of
[Ca2+]i is described in
the online-only Materials and Methods (available in an online-only data
supplement at http://www.circresaha.org). Myocyte cell area was
calculated with NIH Image software (version 1.60, NIH) at the
end-diastolic phase.
Experimental Protocols
Myocytes were superfused with HEPES-buffered solution of the
following composition (in mmol/L): NaCl 137, KCl 3.7,
MgCl2 0.5, HEPES (free acid) 4.0,
CaCl2 1.5, glucose 5.6, and probenecid 0.5, with
final pH 7.40 at 25°C. At baseline, myocytes were paced with field
stimulation at 0.5 Hz with 1.5 mmol/L
[Ca2+]o at 25°C. To
study contractile reserve at high work states, the
[Ca2+]o was increased to
2.5 and 4.0 mmol/L. Measurements were made after 3 minutes at each
level of elevated
[Ca2+]o. In separate
experiments, the pacing frequency was increased to 1, 2, 3, 4, and 5
Hz. Measurements were made after 1 minute at each stimulation
frequency.
Assessment of SR Ca2+ Load
The Ca2+ content of the SR was assessed
through the rapid application of caffeine (10
mmol/L)6 with a rapid solution switcher.7 In
voltage-clamped cells, SR Ca2+ content was
determined by measuring the integral of the caffeine-induced inward
INa/Ca.8 In separate
experiments, in unclamped cells loaded with fluo-3, the peak of the
[Ca2+]i transient induced
by 0 Na+/0 Ca2+ solution
with caffeine was used as an index of the SR Ca2+
load.9 At baseline, similar results were obtained with
both methods, and the latter approach was used to measure SR
Ca2+ load at high work states.
Gene Expression and Protein Levels in LV Tissue
Total RNA was extracted from LV tissue and purified with TRI
Reagent (Sigma Chemical Co). Northern blots were performed as
previously described to assess mRNA levels of ß-myosin heavy chain,
atrial natriuretic peptide, and SR
Ca2+-ATPase (SERCA2).4 10 For
Western blot analyses, LV tissue was frozen and stored at
-80°C until use. Western blotting was performed to assess protein
levels of phospholamban (PLB), the
Na+-Ca2+ exchanger, and
SERCA2 and were normalized to GAPDH.10
SERCA2 Protein Levels in Myocytes
In addition, freshly dissociated LV myocytes were
homogenized in buffer containing 20 mmol/L Tris-HCl,
20 mmol/L NaCl, 0.1 mmol/L EDTA, 0.1% Triton X-100, and
0.5% deoxycholate. Fifty micrograms of protein was loaded onto a 10%
SDS gel and then transferred to a nitrocellulose
membrane.10 The filter was incubated with anti-SERCA2a
antibody (Affinity Bioreagents, Inc). After incubation with anti-mouse
HRP (Sigma Chemical Co), blots were normalized to protein levels of
cyclophilin A (Upstate Biotechnology Inc).
Statistical Analysis
Values are expressed as mean±SEM. Comparisons among the groups
were analyzed by ANOVA followed by a post hoc test. Two-way
ANOVA with repeated measures was used to compare the values measured in
the groups in response to the stepped increases in
[Ca2+]o and the increases
in pacing frequency. Statistical significance was accepted at the level
of P<0.05.
An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.
| Results |
|---|
|
|
|---|
|
|
Contractile reserve at high work state was studied by increasing
[Ca2+]o to 2.5 and
4.0 mmol/L at a constant pacing frequency of 0.5 Hz.
Representative tracings from control and 7-week AS
myocytes are shown in Figure 1
online (available in an online-only data
supplement at http://www.circresaha.org). Diastolic cell
length decreased slightly, but there were no differences among the
groups (Figure 2A
). In control and 4-week
AS myocytes, both fractional cell shortening and peak-systolic
[Ca2+]i increased in
response to the increased
[Ca2+]o (Figures 2B
and 2C
). In contrast, in 7-week AS myocytes, fractional cell
shortening was severely depressed compared with controls (7.9±1.1%
versus 12.2±0.9% at 4.0 mmol/L
[Ca2+]o,
P<0.001, Figure 2B
) in association with reduced
peak-systolic
[Ca2+]i (422±41 versus
666±56 nmol/L at 4.0 mmol/L
[Ca2+]o,
P<0.001, Figure 2C
). The decay of
[Ca2+]i transients
accelerated in control and 4-week AS myocytes as
[Ca2+]o increased,
whereas it did not change in 7-week AS myocytes (data not shown). The
relationship between myocyte shortening and peak-systolic
[Ca2+]i in control and AS
myocytes is shown in Figure 2D
.
|
We also examined frequency-dependent contractile response in AS and
control myocytes. Representative tracings from control
and 7-week AS myocytes are shown in Figure 2
online (available in an
online-only data supplement at http://www.circresaha.org).
Diastolic cell length decreased slightly as pacing
frequency was increased, and there were no differences among the groups
(Figure 3A
). When pacing frequency was
increased from 0.5 to 1 Hz, fractional cell shortening tended to
decline; however, when the pacing frequency was increased to 2, 3, 4,
and 5 Hz, fractional shortening and peak-systolic
Ca2+ significantly increased in both control and
4-week AS myocytes (Figure 3B
). In contrast, fractional cell
shortening decreased during rapid pacing in the 7-week AS myocytes
(4.7±0.8% at 0.5 Hz versus 3.0±0.4% at 5 Hz, P<0.005,
Figure 3B
) in association with impaired augmentation of
peak-systolic
[Ca2+]i (360±28 nmol/L
at 0.5 Hz versus 576±54 nmol/L at 5 Hz, P=0.074, Figure 3C
). In all groups, time to peak shortening decreased as pacing
frequency increased, time to peak
[Ca2+]i did not change,
and both relengthening and decline in
[Ca2+]i accelerated (data
not shown). These data show that contractile reserve in response to the
elevation of perfusate Ca2+, as well as
the challenge of rapid pacing, is depressed in 7-week AS myocytes
compared with control and 4-week AS myocytes. This defect in the 7-week
AS myocytes is related to the failure to augment peak-systolic
[Ca2+]i.
|
Because the amount of Ca2+ release from the SR is
affected by SR Ca2+ content,6 11 SR
Ca2+ load was measured in 7-week AS and controls
(Figure 4
). SR Ca2+
load was similar in 7-week AS and controls under baseline conditions in
either voltage-clamped cells, in which the integral (nA · ms=pC)
of the caffeine-induced inward INa/Ca
normalized by cell capacitance was measured8
(0.87±0.11 versus 0.89±0.07 pC/pF) or unclamped fluo-3loaded cells,
in which the peak of the
[Ca2+]i transient induced
by 0 Na+/0 Ca2+ solution
with caffeine was measured9 (627±54 versus 666±55
nmol/L). The latter method was then used to measure SR
Ca2+ load in response to the challenge of high
[Ca2+]o, as well as rapid
pacing (n=8 to 13 myocytes per group). In response to the stimulus of
high [Ca2+]o (3.0
mmol/L), SR Ca2+ load was lower in 7-week AS than
in controls (665±58 versus 956±52 nmol/L, P<0.005). In
response to rapid pacing (3 Hz), SR Ca2+ load was
lower in 7-week AS (761±73 versus 1003±91 nmol/L,
P<0.05). These experiments suggest that the impaired
augmentation of peak-systolic
[Ca2+]i in 7-week AS
myocytes is in part attributed to impaired SR
Ca2+ loading under high work states.
|
LV message levels of ß-myosin heavy chain (ß-MHC) and atrial
natriuretic peptide (ANP) are increased in both 4-week and
7-week AS mice compared with control mice, whereas mRNA levels of
SERCA2 are increased in 4-week AS mice relative to control mice
(1.68±0.07 versus 1.38±0.06 densitometric units, P<0.01).
On the other hand, SERCA2 mRNA levels are depressed in 7-week AS mice
compared with control mice (0.91±0.10 versus 1.29±0.04 densitometric
units, P<0.001, Figure 5A
).
The protein levels of SERCA2 in isolated LV myocytes are also reduced
in 7-week AS mice compared with control mice (1.44±0.25 versus
2.28±0.06 densitometric units, P<0.05, Figure 5B
),
whereas the SERCA2 protein levels in myocytes from 4-week AS mice are
similar to those from control mice (data not shown).
|
In additional animals, Western blots of SERCA2, PLB, and
Na+-Ca2+ exchanger in LV
tissue were performed. As shown in Figure 6
, the protein levels of the
Na+-Ca2+ exchanger and PLB
are increased both in 4-week and 7-week AS compared with age-matched
controls. The SERCA2-to-PLB protein ratio is depressed in 7-week AS
compared with controls (0.49±0.02 versus 1.04±0.08,
P<0.0005), whereas the ratio is similar in 4-week AS and
controls (1.06±0.28 versus 1.10±0.17, Figure 6C
).
|
| Discussion |
|---|
|
|
|---|
Contractility in Normal Mouse Myocytes
Normal mouse myocytes exhibit a positive frequency-shortening
relationship at >1 Hz, as well as a robust increase in
contractility in response to the elevation of
[Ca2+]o. Using mouse
trabeculae, Gao et al12 observed a similar
response to the elevation of
[Ca2+]o and a positive
force-frequency relationship in the range of 0.2 to 4 Hz at room
temperature. Our observations are also consistent with the
biphasic shortening-frequency response reported by Borzak et
al,13 who observed a negative staircase at <1 Hz and a
positive staircase at >1 Hz in rat myocytes. This biphasic frequency
response is not usually observed in muscle preparations of larger
mammals, including humans, and may be related in part to species
differences in the relative contribution of SERCA2 and
Na+-Ca2+ exchanger for
Ca2+ homeostasis.14 15
Contractile Reserve in Hypertrophied and Failing Mouse
Myocytes
We characterized the mouse model of chronic pressure overload due
to ascending AS and observed that both 4-week and 7-week AS mice
develop severe concentric hypertrophy relative to control
mice. However, 4-week AS mice exhibit normal indices of
systolic performance in vivo, whereas 7-week AS mice
show a depression of LV endocardial and midwall shortening and LV
systolic pressure development.4 5 Human
hemodynamic studies have shown that changes in LV
geometry with concentric remodeling may partially mask intrinsic
changes in contractile function.16 We also observed
abnormal cellcell and cellmatrix connectivity in 7-week AS
mice.5 These factors could confound an assessment of
contractile function in vivo or in isolated muscle preparations.
Therefore, we examined contractile function in isolated LV
hypertrophied myocytes from this model.
In contemporary studies of mouse myocyte contractility,
it is common for conditions of low frequency stimulation and room
temperature in isolated myocytes8 and muscle
preparations12 to enhance stability. Increases in
temperature accelerate all Ca2+ transport
systems, although the relative contributions remain the
same.17 18 Under the baseline conditions of low workload
in the present experiments, only subtle differences in the kinetics
of contraction between normal and hypertrophied mouse myocytes are
present. However, under a high work state induced by the increase
in perfusate Ca2+ concentration, myocyte
shortening is severely depressed in 7-week AS myocytes but not in
4-week AS myocytes, in association with the impaired augmentation of
peak-systolic
[Ca2+]i. Reduced levels
of peak-systolic
[Ca2+]i, as well as
reduced rates of myocyte shortening and relengthening, have also been
observed in myocytes from several animal models of heart
failure,19 20 21 22 as well as in muscle and myocyte
preparations from patients with end-stage dilated
cardiomyopathy.23 24 However, no data
are yet available that characterize
Ca2+-dependent contractile reserve from myocytes
or muscle preparations from humans with adaptive
hypertrophy or early heart failure. In the present
study, myofilament sensitivity to Ca2+ was not
measured. However, over the range of
[Ca2+]o used in our
experiments, the relationship between myocyte shortening and
peak-systolic
[Ca2+]i in hypertrophied
myocytes is similar to that in controls (Figure 2D
), implying
that impaired contractile reserve is not predominantly related to an
alteration in the responsiveness to Ca2+.
Frequency-dependent contractile reserve is also depressed in 7-week AS myocytes, but not in 4-week AS myocytes, compared with control myocytes. In 7-week AS myocytes, fractional cell shortening is depressed at 5 Hz compared with 0.5 Hz, whereas peak-systolic [Ca2+]i tends to be higher at 5 Hz than at 0.5 Hz. This suggests that an alteration in myofilament responsiveness to Ca2+, as well as impaired augmentation of peak-systolic [Ca2+]i, may contribute to the depressed frequency-dependent contractile reserve in 7-week AS myocytes. Pieske et al23 reported that both peak tension and peak-systolic [Ca2+]i increase in muscle preparations from nonfailing hearts in response to increases in pacing frequency, whereas both parameters decrease in muscle preparations from end-stage failing dilated cardiomyopathic hearts. Thus, our observations partially simulate the abnormal systolic force-frequency relationship in failing human cardiac muscle preparations.
Factors That Contribute to Impaired Contractile Reserve
The upregulation of ß-MHC isoform modifies the extent of
shortening and force development as well as its
kinetics,25 26 and ANP has the potential to depress
contractility via the activation of
cGMP.27 However, these mechanisms are unlikely to underlie
our findings, because both ß-MHC and ANP are markedly upregulated in
both 4-week and 7-week AS. Protein levels of PLB and
Na+-Ca2+ exchanger are also
upregulated in both 4-week and 7-week AS. In contrast, SERCA2 protein
levels are increased only in 4-week AS mice, not in 7-week AS mice, in
comparison with age-matched control mice. Moreover, the SERCA2-to-PLB
ratio, which is a major determinant of cardiac
contractility and SR function,1 28 is
decreased only in the 7-week AS mice. These data support the hypothesis
that the upregulation of PLB with its inhibitory effects on
SR Ca2+ uptake, without the concomitant increase
in SERCA2 protein levels, contributes to the impaired contractile
reserve in 7-week AS mouse myocytes at the stage of early failure.
However, the effects of PLB on SR Ca2+ load
cannot be inferred from measurements of message or protein levels,
because dynamic alterations in the phosphorylation
state modify the effects on the affinity of SERCA2 for
Ca2+.29 30 31 32
Reduced SR Ca2+ Loading
Therefore, we measured SR Ca2+ load at
baseline and during an increase in work state in response to an
increase in perfusate Ca2+, as well as an
increase in stimulation frequency, in 7-week AS and control myocytes.
SR Ca2+ loading is depressed in 7-week AS
myocytes under high work states, although there is no difference under
baseline conditions compared with controls. These results are
consistent with the report by Pieske et al,33 who
observed an impaired augmentation of SR Ca2+
loading only at high pacing frequency in human heart muscle.
In human cardiomyopathy, the upregulation of the Na+-Ca2+ exchanger partially compensates for downregulation of SERCA2 and protects against the frequency-dependent rise in diastole force and slowing of force decay.34 In comparison with humans and large mammals, rodents have a higher dependence on SERCA2 relative to Na+-Ca2+ exchanger in competition for cytosolic Ca2+.14 15 In the mouse, relatively high resting intracellular Na+ levels also favor SR Ca2+ uptake rather than forward Na+-Ca2+ exchange for Ca2+ removal.8 However, in 7-week AS myocytes, where the SERCA2-to-PLB ratio is reduced by 50% and the Na+-Ca2+ exchanger protein levels are increased by 2-fold, the calcium ions released from the SR could be preferentially removed from cytosol by the Na+-Ca2+ exchanger. The increased Ca2+ extrusion by the Na+-Ca2+ exchanger may protect hypertrophied myocytes from diastolic dysfunction; however, the increased Ca2+ removal may contribute to the reduction in SR Ca2+ load and impaired augmentation of systolic [Ca2+]i, during high work states.
These findings do not exclude a contribution of other mechanisms to the reduced levels of systolic [Ca2+]i in the 7-week AS myocytes, including decreased efficacy of Ca2+-induced Ca2+ release35 36 due to impaired ryanodine channel responsiveness,37 differences in sarcolemmal subspace [Ca2+]i,38 or changes in proteins involved in the SR Ca2+ release cascade.9 39 SR Ca2+ release is sensitive to ICa, L and SR Ca2+ load.6 11 A depressed "gain" in the coupling of SR Ca2+ release in response to ICa, L has been observed in failing rat myocytes, which has the potential to modify peak-systolic [Ca2+]i levels.35 Shannon and Bers40 reported that fractional SR Ca2+ release increases in a nonlinear manner, with the relationship becoming much steeper at higher SR Ca2+ content. Thus, any change in SR Ca2+ content itself during high work states has the potential to modulate the gain function and the amplitude of the [Ca2+]i transient.11 36
SR Ca2+ Load and Hypertrophy
The effects of pressure overload hypertrophy on SR
Ca2+ load appear to depend on both the
experimental study conditions and the stage of hypertrophy.
Shorofsky et al41 reported an enhanced SR
Ca2+ release without alterations in
ICa, L density or kinetics, SR function, or
the expression of Ca2+ cycling proteins in rats
with compensatory hypertrophy. Delbridge et
al42 examined hypertrophied rat myocytes under
steady-state voltage-clamped conditions and observed no change in SR
Ca2+ load or amount of Ca2+
released per twitch. Using voltage-clamped myocytes from the same model
after field stimulation to load the SR, McCall et al9
observed no difference in myocyte SR Ca2+ load
during a caffeine-induced transient; in this study, fractional SR
Ca2+ release in response to a given
ICa, L trigger was the same under baseline
conditions but depressed under a low
[Ca2+]o of 0.5
mmol/L. In contrast, in this same rat model, SR
Ca2+ content estimated by rapid cooling
contractures was depressed at higher pacing frequency and after long
rest intervals.43 The present study in normal and
hypertrophied mouse myocytes illustrates the importance of an
assessment of myocyte contractile function and
Ca2+ regulation under variable work
conditions and at differing stages in the natural history of
hypertrophy.
| Acknowledgments |
|---|
Received July 5, 2000; revision received August 7, 2000; accepted August 7, 2000.
| References |
|---|
|
|
|---|
2.
Luo W, Grupp IL, Harrer M, Ponniah S, Grupp G, Duffy
JJ, Doetschman T, Kranias EG. Targeted ablation of the phospholamban
gene is associated with markedly enhanced myocardial
contractility and loss of ß-agonist stimulation.
Circ Res. 1994;75:401409.
3.
Rouslin W, Broge CW. Isoform-independent heart
rate-related variation in cardiac myofibrillar
Ca2+-activated
Mg2+-ATPase activity. Am J
Physiol. 1996;270:C1271C1276.
4.
Ding B, Price RL, Borg TK, Weinberg EO, Halloran PF,
Lorell BH. Pressure overload induces severe hypertrophy in
mice treated with cyclosporine, an inhibitor of
calcineurin. Circ Res. 1999;84:729734.
5.
Ding B, Price RL, Goldsmith EC, Borg TK, Yan X,
Douglas PS, Weinberg EO, Bartunek J, Thielen T, Didenko V, Lorell BH.
Left ventricular hypertrophy in ascending
aortic stenosis mice: anoikis and the progression to early
failure. Circulation. 2000;101:28542862.
6.
Bassani JWM, Yuan W, Bers DM. Fractional SR Ca release
is regulated by trigger Ca and SR Ca content in cardiac myocytes.
Am J Physiol. 1995;268:C1313C1319.
7.
Spitzer KW, Bridge JHB. A simple device for rapidly
exchanging solution surrounding a single cell. Am J
Physiol. 1989;256:C441C447.
8.
Yao A, Su Z, Nonaka A, Zubair I, Lu L, Philipson KD,
Bridge JHB, Barry WH. Effects of overexpression of
Na+-Ca2+ exchanger on
[Ca2+]i transients in
murine ventricular myocytes. Circ Res. 1998;82:657665.
9.
McCall E, Ginsburg KS, Bassani RA, Shannon TR, Qi M,
Samarel AM, Bers DM. Ca flux, contractility, and
excitation-contraction coupling in hypertrophic rat
ventricular myocytes. Am J Physiol. 1998;274:H1348H1360.
10.
Tajima M, Weinberg EO, Bartunek J, Jin H, Yang R, Paoni
NF, Lorell BH. Treatment with growth hormone enhances contractile
reserve and intracellular calcium transients in myocytes from rats with
postinfarction heart failure. Circulation. 1999;99:127134.
11. Shannon TR, Ginsburg KS, Bers DM. Potentiation of fractional sarcoplasmic reticulum calcium release by total and free intra-sarcoplasmic reticulum calcium concentration. Biophys J. 2000;78:334343.[Medline] [Order article via Infotrieve]
12.
Gao WD, Perez NG, Marban E. Calcium cycling and
contractile activation in intact mouse cardiac muscle. J
Physiol (Lond). 1998;507:175184.
13.
Borzak S, Murphy S, Marsh JD. Mechanisms of rate
staircase in rat ventricular cells. Am J
Physiol. 1991;260:H884H892.
14. Bers DM, Bassani JWM, Bassani RA. Na-Ca exchange and Ca fluxes during contraction and relaxation in mammalian ventricular muscle. Ann N Y Acad Sci. 1996;779:430442.[Medline] [Order article via Infotrieve]
15.
Bassani JW, Bassani RA, Bers DM. Relaxation in rabbit
and rat cardiac cells: species-dependent differences in cellular
mechanisms. J Physiol (Lond). 1994;476:279293.
16. Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol. 1995;26:195202.[Abstract]
17. Marengo FD, Wang S-Y, Langer GA. The effects of temperature upon calcium exchange in intact cultured cardiac myocytes. Cell Calcium. 1997;21:263273.[Medline] [Order article via Infotrieve]
18.
Puglisi IL, Bassani RA, Bassani JW, Amin JN, Bers DM.
Temperature and relative contributions of Ca transport systems in
cardiac myocyte relaxation. Am J Physiol. 1996;270:H1772H1778.
19.
ORourke B, Kass D, Tomaselli GF, Kaab S, Tunin R,
Marban E. Mechanisms of altered excitation-contraction coupling in
canine tachycardia-induced heart failure, I: experimental
studies. Circ Res. 1999;84:562570.
20.
Yao A, Su Z, Nonaka A, Zubair I, Spitzer KW, Bridge
JHB, Muelheims G, Ross J Jr, Barry WH. Abnormal myocyte
Ca2+ homeostasis in rabbit with pacing-induced
heart failure. Am J Physiol. 1998;275:H1441H1448.
21. Bailey BA, Houser SR. Calcium transients in feline left ventricular myocytes with hypertrophy induced by slow progressive pressure overload. J Mol Cell Cardiol. 1992;24:365373.[Medline] [Order article via Infotrieve]
22.
Siri FM, Krueger J, Nordin C, Ming Z, Aronson RS.
Depressed intracellular calcium transients and contraction in myocytes
from hypertrophied and failing guinea pig hearts. Am J
Physiol. 1991;261:H514H530.
23.
Pieske B, Kretschmann B, Meyer M, Holubarsch C, Weirich
J, Posival H, Minami K, Just H, Hasenfuss G. Alterations in
intracellular calcium handling associated with the inverse
force-frequency relation in human dilated
cardiomyopathy. Circulation. 1995;92:11691178.
24.
Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular
calcium handling in isolated ventricular myocytes from
patients with terminal heart failure. Circulation. 1992;85:10461055.
25.
Fitzsimons DP, Patel JR, Moss RL. Role of myosin heavy
chain composition in kinetics of force development and relaxation in
rat myocardium. J Physiol (Lond). 1998;513:171183.
26.
Schiaffino S, Reggiani C. Molecular diversity of
myofibrillar proteins: gene regulation and functional significance.
Physiol Rev. 1996;76:371423.
27.
Tajima M, Bartunek J, Weinberg EO, Ito N, Lorell BH.
Atrial natriuretic peptide has different effects on
contractility and intracellular pH in normal and
hypertrophied myocytes from pressure-overloaded hearts.
Circulation. 1998;98:27602764.
28.
Luo W, Wolska BM, Grupp IL, Harrer JM, Haghighi K,
Ferguson DG, Slack JP, Grupp G, Doetschman T, Solaro RJ, Kranias EG.
Phospholamban gene dosage effects in the mammalian heart. Circ
Res. 1996;78:839847.
29.
Chu G, Dorn GWII, Luo W, Harrer JM, Kadambi VJ, Walsh
RA, Kranias EG. Monomeric phospholamban overexpression in transgenic
mouse hearts. Circ Res. 1997;81:485492.
30.
Netticadan T, Temsah RM, Kawabata K, Dhalla NS.
Sarcoplasmic reticulum
Ca2+/calmodulin-dependent protein
kinase is altered in heart failure. Circ Res. 2000;86:596605.
31.
Schmidt U, Hajjar RJ, Kim CS, Lebeche D, Doye AA,
Gwathmey JK. Human heart failure: cAMP stimulation of SR
Ca2+-ATPase activity and
phosphorylation level of phospholamban. Am J
Physiol. 1999;277:H474480.
32. Schwinger RHG, Munch G, Bolck B, Karczewski P, Krause E-G, Erdmann E. Reduced Ca2+-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol. 1999;31:479491.[Medline] [Order article via Infotrieve]
33.
Pieske B, Maier LS, Bers DM, Hasenfuss G.
Ca2+ handling and sarcoplasmic reticulum
Ca2+ content in isolated failing and nonfailing
human myocardium. Circ Res. 1999;85:3846.
34.
Hasenfuss G, Schillinger W, Lehnart SE, Preuss M,
Piesle B, Maier LS, Prestle J, Minami K, Just H. Relationship between
Na+-Ca2+-exchanger protein
levels and diastolic function of failing human
myocardium. Circulation. 1999;99:641648.
35.
Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF,
Cannell MB, McCune SA, Altschuld RA, Lederer WJ. Defective
excitation-contraction coupling in experimental cardiac
hypertrophy and heart failure. Science. 1997;276:800806.
36.
Santana LF, Kranias EG, Lederer WJ. Calcium sparks and
excitation-contraction coupling in phospholamban-deficient mouse
ventricular myocytes. J Physiol (Lond). 1997;503:2129.
37.
Nimer LR, Needleman DH, Hamilton SL, Krall J, Movesian
MA. Effect of ryanodine on sarcoplasmic reticulum
Ca2+ accumulation in nonfailing and failing human
myocardium. Circulation. 1995;92:25042510.
38. Yao A, Spitzer KW, Ito N, Zaniboni M, Lorell BH, Barry WH. The restriction of diffusion of cations at the external surface of cardiac myocytes varies between species. Cell Calcium. 1997;22:431438.[Medline] [Order article via Infotrieve]
39. Jones LR, Suzuki YJ, Wang W, Kobayashi YM, Ramesh V, Franzini-Armstrong C, Cleemann L, Morad M. Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest. 1998;191:13851393.
40. Shannon TR, Bers DM. Assessment of intra-SR free [Ca] and buffering in rat heart. Biophys J. 1997;73:15241531.[Medline] [Order article via Infotrieve]
41.
Shorofsky SR, Aggarwal R, Corretti M, Baffa JM, Strum
JM, Al-Seikhan BA, Kobayashi YM, Jones LR, Wier WG, Balke CW. Cellular
mechanisms of altered contractility in the
hypertrophied heart: big hearts, big sparks. Circ Res. 1999;84:424434.
42.
Delbridge LMD, Satoh H, Yuan W, Bassani JWM, Qi M,
Ginsburg KS, Samarel AM, Bers DM. Cardiac myocyte volume,
Ca2+ fluxes, and sarcoplasmic reticulum loading
in pressure-overload hypertrophy. Am J
Physiol. 1997;272:H2425H2435.
43.
Maier LS, Brandes R, Pieske B, Bers DM. Effects of left
ventricular hypertrophy on force and
Ca2+ handling in isolated rat
myocardium. Am J Physiol. 1998;274:H1361H1370.
This article has been cited by other articles:
![]() |
R J Hassink, H Nakajima, H O Nakajima, P A Doevendans, and L J Field Expression of a transgene encoding mutant p193/CUL7 preserves cardiac function and limits infarct expansion after myocardial infarction Heart, July 15, 2009; 95(14): 1159 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Unno, S. Isobe, H. Izawa, X. W. Cheng, M. Kobayashi, A. Hirashiki, T. Yamada, K. Harada, S. Ohshima, A. Noda, et al. Relation of functional and morphological changes in mitochondria to myocardial contractile and relaxation reserves in asymptomatic to mildly symptomatic patients with hypertrophic cardiomyopathy Eur. Heart J., May 24, 2009; (2009) ehp184v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Mork, I. Sjaastad, O. M. Sejersted, and W. E. Louch Slowing of cardiomyocyte Ca2+ release and contraction during heart failure progression in postinfarction mice Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1069 - H1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yan, A. J. T. Schuldt, R. L. Price, I. Amende, F.-F. Liu, K. Okoshi, K. K. L. Ho, A. J. Pope, T. K. Borg, B. H. Lorell, et al. Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1274 - H1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Dibb, D. A. Eisner, and A. W. Trafford Regulation of systolic [Ca2+]i and cellular Ca2+ flux balance in rat ventricular myocytes by SR Ca2+, L-type Ca2+ current and diastolic [Ca2+]i J. Physiol., December 1, 2007; 585(2): 579 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Belke, B. Gloss, E. A. Swanson, and W. H. Dillmann Adeno-Associated Virus-Mediated Expression of Thyroid Hormone Receptor Isoforms-{alpha}1 and -{beta}1 Improves Contractile Function in Pressure Overload-Induced Cardiac Hypertrophy Endocrinology, June 1, 2007; 148(6): 2870 - 2877. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Armoundas, J. Rose, R. Aggarwal, B. D. Stuyvers, B. O'Rourke, D. A. Kass, E. Marban, S. R. Shorofsky, G. F. Tomaselli, and C. William Balke Cellular and molecular determinants of altered Ca2+ handling in the failing rabbit heart: primary defects in SR Ca2+ uptake and release mechanisms Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1607 - H1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kilic, T. Li, T. D.C. Nolan, J. R. Nash, S. Li, D. J. Prastein, G. Schwartzbauer, S. L. Moainie, G. K. Yankey, C. DeFilippi, et al. Strain-related regional alterations of calcium-handling proteins in myocardial remodeling J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 900 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. R. Carvalho, R. A. Bassani, K. G. Franchini, and J. W. M. Bassani Enhanced calcium mobilization in rat ventricular myocytes during the onset of pressure overload-induced hypertrophy Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1803 - H1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Sirenko, J. D. Potter, and B. C. Knollmann Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts - role of myofilament Ca2+ sensitivity increase J. Physiol., August 15, 2006; 575(1): 201 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Fowler, J. R. Naz, M. D. Graham, G. Bru-Mercier, S. M. Harrison, and C. H. Orchard Decreased Ca2+ extrusion via Na+/Ca2+ exchange in epicardial left ventricular myocytes during compensated hypertrophy Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2431 - H2438. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Dibb, C. L. Hagarty, A. S. I. Loudon, and A. W. Trafford Photoperiod-dependent modulation of cardiac excitation contraction coupling in the Siberian hamster Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R607 - R614. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakayama, X. Yan, R. L. Price, T. K. Borg, K. Ito, A. Sanbe, J. Robbins, and B. H. Lorell Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H317 - H327. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang, S. Dostanic, N. Servant, and L. E. Chalifour Egr-1 negatively regulates expression of the sodium-calcium exchanger-1 in cardiomyocytes in vitro and in vivo Cardiovasc Res, January 1, 2005; 65(1): 187 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rubart Two-Photon Microscopy of Cells and Tissue Circ. Res., December 10, 2004; 95(12): 1154 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Bondarenko, G. P. Szigeti, G. C. L. Bett, S.-J. Kim, and R. L. Rasmusson Computer model of action potential of mouse ventricular myocytes Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1378 - H1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yan, R. L. Price, M. Nakayama, K. Ito, A. J. T. Schuldt, W. J. Manning, A. Sanbe, T. K. Borg, J. Robbins, and B. H. Lorell Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2179 - H2187. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rubart, K. B.S. Pasumarthi, H. Nakajima, M. H. Soonpaa, H. O. Nakajima, and L. J. Field Physiological Coupling of Donor and Host Cardiomyocytes After Cellular Transplantation Circ. Res., June 13, 2003; 92(11): 1217 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rubart, E. Wang, K. W. Dunn, and L. J. Field Two-photon molecular excitation imaging of Ca2+ transients in Langendorff-perfused mouse hearts Am J Physiol Cell Physiol, June 1, 2003; 284(6): C1654 - C1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M Pogwizd, K. R Sipido, F. Verdonck, and D. M Bers Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis Cardiovasc Res, March 15, 2003; 57(4): 887 - 896. [Full Text] [PDF] |
||||
![]() |
W. Schillinger, J. W Fiolet, K. Schlotthauer, and G. Hasenfuss Relevance of Na+-Ca2+ exchange in heart failure Cardiovasc Res, March 15, 2003; 57(4): 921 - 933. [Full Text] [PDF] |
||||
![]() |
S. R. Houser and K. B. Margulies Is Depressed Myocyte Contractility Centrally Involved in Heart Failure? Circ. Res., March 7, 2003; 92(4): 350 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ito, M. Nakayama, F. Hasan, X. Yan, M. D. Schneider, and B. H. Lorell Contractile Reserve and Calcium Regulation Are Depressed in Myocytes From Chronically Unloaded Hearts Circulation, March 4, 2003; 107(8): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sjaastad, J A. Wasserstrom, and O. M Sejersted Heart failure - a challenge to our current concepts of excitation-contraction coupling J. Physiol., January 1, 2003; 546(1): 33 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Liao, M. Jain, L. Cui, J. D'Agostino, F. Aiello, I. Luptak, S. Ngoy, R. M. Mortensen, and R. Tian Cardiac-Specific Overexpression of GLUT1 Prevents the Development of Heart Failure Attributable to Pressure Overload in Mice Circulation, October 15, 2002; 106(16): 2125 - 2131. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R Sipido, P. G.A Volders, M. A Vos, and F. Verdonck Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy? Cardiovasc Res, March 1, 2002; 53(4): 782 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kiriazis, Y. Sato, V. J Kadambi, A. G Schmidt, M. J Gerst, B. D Hoit, and E. G Kranias Hypertrophy and functional alterations in hyperdynamic phospholamban-knockout mouse hearts under chronic aortic stenosis Cardiovasc Res, February 1, 2002; 53(2): 372 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sugishita, Z. Su, F. Li, K. D. Philipson, and W. H. Barry Gender Influences [Ca2+]i During Metabolic Inhibition in Myocytes Overexpressing the Na+-Ca2+ Exchanger Circulation, October 23, 2001; 104(17): 2101 - 2106. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Somura, H. Izawa, M. Iwase, Y. Takeichi, R. Ishiki, T. Nishizawa, A. Noda, K. Nagata, Y. Yamada, and M. Yokota Reduced Myocardial Sarcoplasmic Reticulum Ca2+-ATPase mRNA Expression and Biphasic Force-Frequency Relations in Patients With Hypertrophic Cardiomyopathy Circulation, August 7, 2001; 104(6): 658 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Barry Na+-Ca2+ Exchange in Failing Myocardium : Friend or Foe? Circ. Res., September 29, 2000; 87(7): 529 - 531. [Full Text] [PDF] |
||||
![]() |
Z. Wang, B. Nolan, W. Kutschke, and J. A. Hill Na+-Ca2+ Exchanger Remodeling in Pressure Overload Cardiac Hypertrophy J. Biol. Chem., May 18, 2001; 276(21): 17706 - 17711. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ito, X. Yan, X. Feng, W. J. Manning, W. H. Dillmann, and B. H. Lorell Transgenic Expression of Sarcoplasmic Reticulum Ca2+ ATPase Modifies the Transition From Hypertrophy to Early Heart Failure Circ. Res., August 31, 2001; 89(5): 422 - 429. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |